Clinical Trials Directory

Trials / Unknown

UnknownNCT03330873

The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome

Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent and Foley Catheter in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Beijing Obstetrics and Gynecology Hospital · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions. The recurrence of intrauterine adhesions is a major challenge in clinical practice. The isolation of barriers in the uterine cavity may be a measure to reduce postoperative re adhesion, but the effect of different devices is different. Therefore, this study was conducted.

Detailed description

The Foley catheter is usually inserted into the uterine after a hysteroscopic adhesiolysis and removed after on the 5-7th day after surgery. Several investigators demonstrated its favorable effect in the recurrence of adhesion after the treatment of intrauterine adhesion. Disposable balloon uterine stent is specially designed to fit into the cavity of the uterus, and usually removed on the 7th day after surgery.

Conditions

Interventions

TypeNameDescription
DEVICEdisposable balloon uterine stentThe disposable balloon uterine stent is heart-shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to Foley catheter
DEVICEFoley catheterFoley catheter can partly separate the sides of uterus wall.

Timeline

Start date
2017-10-23
Primary completion
2018-08-20
Completion
2018-10-20
First posted
2017-11-06
Last updated
2017-11-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03330873. Inclusion in this directory is not an endorsement.